Publicacións (309) Publicacións de RUBEN NOGUEIRAS POZO

2024

  1. Antiobesity effects of intestinal gluconeogenesis are mediated by the brown adipose tissue sympathetic nervous system

    Obesity, Vol. 32, Núm. 4, pp. 710-722

  2. Correction to: Seeing through the fog: a neuroendocrine explanation for post-COVID cognitive deficits (Nature Reviews Endocrinology, (2024), 20, 4, (189-190), 10.1038/s41574-024-00955-3)

    Nature Reviews Endocrinology

  3. Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes

    DIABETES THERAPY

  4. Hypothalamic free fatty acid receptor-1 regulates whole-body energy balance

    Molecular Metabolism, Vol. 79

  5. Localization, traffic and function of Rab34 in adipocyte lipid and endocrine functions

    Journal of Biomedical Science, Vol. 31, Núm. 1

  6. Seeing through the fog: a neuroendocrine explanation for post-COVID cognitive deficits

    Nature Reviews Endocrinology

  7. The effects of ghrelin and LEAP-2 in energy homeostasis are modulated by thermoneutrality, high-fat diet and aging

    Journal of Endocrinological Investigation

  8. p63 controls metabolic activation of hepatic stellate cells and fibrosis via an HER2-ACC1 pathway

    Cell Reports Medicine, Vol. 5, Núm. 2

2023

  1. A longitudinal study of free leptin index in pre-eclamptic pregnancies

    Journal of Cellular and Molecular Medicine, Vol. 27, Núm. 8, pp. 1083-1094

  2. CaMK1D signalling in AgRP neurons promotes ghrelin-mediated food intake

    Nature Metabolism, Vol. 5, Núm. 6, pp. 1045-1058

  3. Expanding the roles of the renin–angiotensin system: Drug-induced liver injury

    Journal of Hepatology

  4. Food odour recognition adjusts systemic metabolism to nutrient availability

    Nature Reviews Endocrinology

  5. Gastric GDF15 levels are regulated by age, sex, and nutritional status in rodents and humans

    Journal of Endocrinological Investigation

  6. Ghrelin

    Current Biology

  7. Gut hormone co-agonists for the treatment of obesity: from bench to bedside

    Nature Metabolism, Vol. 5, Núm. 6, pp. 933-944

  8. Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy

    Diabetologia, Vol. 66, Núm. 10, pp. 1796-1808

  9. Hepatic levels of S-adenosylmethionine regulate the adaptive response to fasting

    Cell Metabolism, Vol. 35, Núm. 8, pp. 1373-1389.e8

  10. Hepatic p63 regulates glucose metabolism by repressing SIRT1

    Gut, Vol. 72, Núm. 3, pp. 472-483

  11. Hepatocyte-specific O-GlcNAc transferase downregulation ameliorates nonalcoholic steatohepatitis by improving mitochondrial function

    Molecular Metabolism, Vol. 75

  12. Human defensin 5-based compounds: a new approach to fight obesity?

    Gut